Verona Pharma Plc ADR (VRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRNA | KYMR | PTGX | ||
| Company | Verona Pharma Plc ADR | Kymera Therapeutics Inc | Protagonist Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 106.85 | 110.25 | 133.34 | ||
| High | 106.93 | 113.09 | 136.49 | ||
| Low | 106.81 | 110.25 | 131.05 | ||
| Latest | 106.91 | 111.26 | 136.77 | ||
| Change | +0.12 | +0.20 | +2.50 | ||
| % Change | +0.11% | +0.18% | +1.86% | ||
| Volume | 1,871,900 | 134,953 | 127,956 | ||
| 20-Day Average Volume | 1,504,320 | 1,129,521 | 877,833 | ||
| Previous Close | 106.79 | 111.06 | 134.27 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 106.48 | 112.49 | 130.38 | ||
| 20-Day Raw Stochastic | 98.26% | 47.45% | 73.63% | ||
| 20-Day Relative Strength | 70.52 | 58.41 | 61.83 | ||
| Weighted Alpha | +201.62 | +118.62 | +127.45 | ||
| Today's Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 72% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.28% since 09/29/25 | -0.58% since 07/14/26 | +3.39% since 07/14/26 | ||
| Low | 106.61 on 09/30/25 | 110.15 on 07/15/26 | 126.97 on 07/15/26 | ||
| High | 106.93 on 10/06/25 | 119.83 on 07/20/26 | 143.29 on 07/20/26 | ||
| 1-Month | |||||
| %Chg | +0.56% since 09/05/25 | +23.22% since 06/18/26 | +20.25% since 06/18/26 | ||
| Low | 105.78 on 09/19/25 | 91.74 on 06/22/26 | 113.24 on 06/22/26 | ||
| High | 106.93 on 10/06/25 | 130.05 on 06/25/26 | 143.29 on 07/20/26 | ||
| 3-Month | |||||
| %Chg | +16.80% since 07/03/25 | +26.52% since 04/21/26 | +28.17% since 04/21/26 | ||
| Low | 86.63 on 07/08/25 | 69.48 on 06/03/26 | 92.75 on 06/02/26 | ||
| High | 106.93 on 10/06/25 | 130.05 on 06/25/26 | 143.29 on 07/20/26 | ||
| 6-Month | |||||
| %Chg | +98.35% since 04/04/25 | +57.52% since 01/21/26 | +61.78% since 01/21/26 | ||
| Low | 47.20 on 04/07/25 | 68.29 on 01/26/26 | 77.00 on 02/23/26 | ||
| High | 106.93 on 10/06/25 | 130.05 on 06/25/26 | 143.29 on 07/20/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,748,446 | 9,135,574 | 8,635,037 | ||
| Shares Outstanding, K | 81,830 | 82,258 | 64,311 | ||
| Annual Sales | 42,280,000 | 39,210,000 | 46,020,000 | ||
| Annual Net Income | -173,420,000 | -311,350,000 | -130,150,000 | ||
| Last Quarter Sales | 103,140,000 | 34,370,000 | 56,370,000 | ||
| Last Quarter Net Income | 11,920,000 | -69,230,000 | 3,780,000 | ||
| 60-Month Beta | 0.05 | 1.95 | 1.79 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.13 on 08/06/25 | -0.71 on 04/30/26 | 0.05 on 05/05/26 | ||
| Earnings Date | 11/03/25 | 08/10/26 | 08/05/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||